Wyniki wyszukiwania:

Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia arising as a consequence of a relative or absolute deficiency of insulin secretion, resistance to insulin action, or both. This is a major and growing public health problem throughout the world, with an estimated worldwide prevalence of 171 million people in 2000, expected to increase to 366 million people by 2030. The pharmacological agents currently used for the treatment of type 2 diabetes mellitus (T2DM) include sulfonylurea, biguanide, thiazolidinedione, and -glycosidase inhibitors. These agents, however, have...